ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
JohnCohen
|
60 |
29K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
JohnCohen
|
60 |
29K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
JohnCohen
|
60 |
29K |
4 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
60
|
29K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Oncosil breakthrough device receives CE Marking approval
|
|
JohnCohen
|
165 |
67K |
12 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
165
|
67K
|
12
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 2A
|
|
JohnCohen
|
15 |
5.9K |
1 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
15
|
5.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 2A
|
|
JohnCohen
|
15 |
5.9K |
5 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
15
|
5.9K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: FDA Grants Breakthrough Device Designation
|
|
JohnCohen
|
31 |
13K |
0 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
31
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
3 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
395
|
273K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: FDA Grants Breakthrough Device Designation
|
|
JohnCohen
|
31 |
13K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
31
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
5 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
395
|
273K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
395
|
273K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: FDA Grants Breakthrough Device Designation
|
|
JohnCohen
|
31 |
13K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
31
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
395
|
273K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
For the sake of something fun
|
|
JohnCohen
|
7 |
3.7K |
1 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
7
|
3.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
For the sake of something fun
|
|
JohnCohen
|
7 |
3.7K |
3 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
7
|
3.7K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
0 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
395
|
273K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
JohnCohen
|
395 |
273K |
1 |
28/01/20 |
28/01/20 |
ASX - By Stock
|
395
|
273K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Positive CE Mark Status Report
|
|
JohnCohen
|
161 |
84K |
5 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
161
|
84K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
0 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
133
|
65K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
0 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
133
|
65K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
0 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
133
|
65K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
1 |
02/04/19 |
02/04/19 |
ASX - By Stock
|
133
|
65K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
2 |
30/03/19 |
30/03/19 |
ASX - By Stock
|
133
|
65K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
2 |
30/03/19 |
30/03/19 |
ASX - By Stock
|
133
|
65K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Update - CE Marking Application
|
|
JohnCohen
|
133 |
65K |
3 |
30/03/19 |
30/03/19 |
ASX - By Stock
|
133
|
65K
|
3
|
|